Skip to main content
. 2004 Oct;87(4):2172–2186. doi: 10.1529/biophysj.104.043000

TABLE 2.

Effects of simulated enzymopathies in glycolytic enzymes on steady-state flux space

Glycolytic enzymes Inline graphic Constraining? Systemic Inline graphic Systemic Inline graphic Restricted Inline graphic Percentage of steady-state flux space remaining Hemolytic anemia?*
Hexokinase (HK) 1.5 Yes 1.50 0.48 0.74 0.02% Yes
Phosphofructokinase (PFK) 250 No 1.58 0.31 0.63 0.21% Variable
Triose phosphate isomerase (TPI) 1000 No 1.58 0.31 0.63 0.21% Yes
Aldolase (ALD) 1000 No 1.58 0.31 0.63 0.21% Yes
Lactate dehydrogenase (LDH) 1000 No 2.81 0.09 0.77 0.56% No
Pyruvate kinase (PK) 250 No 3.21 1.17 1.68 0.83% Yes
Enolase (EN) 1000 No 3.21 1.17 1.68 0.84% Yes
Phosphoglucoisomerase (PGI) 1000 No 1.48 −0.77 −0.21 1.0% Yes
Phosphoglycerate kinase (PGK) 1000 No 2.91 0.87 1.38 2.2% Usually
Diphosphoglycerate phosphatase (DPGase) 0.52 Yes 0.52 0.3 0.36 29% No
Diphosphoglyceromutase (DPGM) 12 No 1.43 0.3 0.58 47% No

Several conditions have been identified that decrease the effectiveness of enzymes in the red blood cells. The effect of a reduction in the possible steady-state ranges of fluxes on the steady-state flux space as a whole was simulated by decreasing the maximum allowable reaction flux through the reaction catalyzed by the given enzyme. The columns of the table show: 1), the enzyme defect being simulated; 2), the corresponding Inline graphic; 3), whether the Inline graphic is constraining on the system; 4), the actual maximum flux rate for the reaction in the network; 5), the actual minimum flux rate (Inline graphic) for the reaction in the network; 6), to what extent Inline graphic is restricted to constrain the allowable flux range for the reaction to one-quarter of its original value; 7), the percentage drop in the volume of the steady-state flux space corresponding to the simulated enzymopathy; and 8), whether defects in an enzyme had been experimentally determined to cause anemia or not.

*

Taken from Tanaka et al. (1990).

HHS Vulnerability Disclosure